1TAKEDA M,KHAMDANG S,NARIKAWA S,et al.Characterization of methotrexate transport and its drug interactions with human organic anion transporters[J].J Pharmacol Exp Ther,2002,302(2):666-671.
2NOZAKI Y,KUSUHARA H,KONDO T,et al.Species difference in the inhibitory effect of nonsteroidal antiinflammatory drugs on the uptake of methotrexate by human kidney slices[J].J Pharmacol Exp Ther,2007,322(3):1162-1170.
3ZHANG L,STRONG J M,QIU W,et al.Scientific perspectives on drug transporters and their role in drug interactions[J].Mol Pharm,2006,3(1):62-69.
4UWAI Y,SAITO H,INUI K.Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter[J].Eur J Pharmacol,2000,409(1):31-36.
5EL-SHEIKH A A,VAN DEN HEUVEL J J,KOENDERINK J B,et al.Interaction of nonsteroidal anti-inflammatory drugs with muitidrug resistance protein(MRP)2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport[J].J Pharmacol Ther,2007,320(1):229-235.
4[5]Malleson PN.Management of childhood arthritis. Part 2:Chronic arthritis.Arch Dis Child,1997,76:541
5[6]Lin YT, Tsai MJ,Wang LH.Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis. J Formos Med Assoc,2000,99(8):623.
6[7]Cron RQ, Sharma S, Sherry DD. Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol,1999,26(9):2036
7[8]Ravelli A, Viola S, Ramenghi B.Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. J Pediatr,1998,133(2):262
8[9]Brooks CD.Sulfasalazine for the management of juvenile rheumatoid arthritis. J Rheumatol,2001,28(4):845
9[10]van Rossum MA, Fiselier TJ, Franssen MJ.Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum,1998,41(5):808
